Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$12.92 - $15.89 $21,059 - $25,900
-1,630 Reduced 11.77%
12,220 $167,000
Q1 2023

May 10, 2023

SELL
$13.67 - $16.37 $75,185 - $90,035
-5,500 Reduced 28.42%
13,850 $212,000
Q4 2022

Feb 09, 2023

SELL
$12.05 - $15.14 $1.84 Million - $2.31 Million
-152,450 Reduced 88.74%
19,350 $259,000
Q3 2022

Nov 10, 2022

SELL
$12.82 - $20.22 $60,638 - $95,640
-4,730 Reduced 2.68%
171,800 $2.28 Million
Q2 2022

Aug 12, 2022

SELL
$17.89 - $20.47 $35,780 - $40,940
-2,000 Reduced 1.12%
176,530 $3.38 Million
Q1 2022

May 16, 2022

SELL
$18.39 - $21.85 $780,471 - $927,314
-42,440 Reduced 19.21%
178,530 $3.56 Million
Q4 2021

Feb 14, 2022

SELL
$18.96 - $22.76 $727,969 - $873,870
-38,395 Reduced 14.8%
220,970 $4.51 Million
Q3 2021

Nov 15, 2021

SELL
$20.59 - $30.01 $702,119 - $1.02 Million
-34,100 Reduced 11.62%
259,365 $5.59 Million
Q1 2021

May 17, 2021

SELL
$19.71 - $25.23 $74,898 - $95,874
-3,800 Reduced 1.28%
293,465 $7.16 Million
Q4 2020

Feb 16, 2021

BUY
$16.44 - $20.2 $1.24 Million - $1.53 Million
75,550 Added 34.08%
297,265 $5.77 Million
Q3 2020

Nov 16, 2020

BUY
$17.36 - $26.36 $1.26 Million - $1.91 Million
72,475 Added 48.56%
221,715 $3.86 Million
Q2 2020

Aug 12, 2020

SELL
$22.31 - $28.29 $671,419 - $851,387
-30,095 Reduced 16.78%
149,240 $3.92 Million
Q1 2020

May 15, 2020

SELL
$17.75 - $27.72 $1.82 Million - $2.84 Million
-102,386 Reduced 36.34%
179,335 $4.34 Million
Q4 2019

Jan 14, 2020

BUY
$21.0 - $24.83 $113,505 - $134,206
5,405 Added 1.96%
281,721 $7 Million
Q3 2019

Oct 31, 2019

BUY
$20.34 - $32.66 $4.37 Million - $7.01 Million
214,708 Added 348.51%
276,316 $5.89 Million
Q2 2019

Jul 31, 2019

BUY
$28.03 - $36.85 $1.73 Million - $2.27 Million
61,608 New
61,608 $1.96 Million

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $440M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.